Press-release for stocks in the wholesale trade sector related to update

Prices are updated after-hours

Kaival Brands Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 12:30) - globenewswire.com
KAVL | $3.51 3.24% 3.13% 340K

| 4.62% | O: -12.92% H: 6.36% C: -0.71%
first business brands update financial results

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
Published: 2024-03-14 (Crawled : 13:30) - globenewswire.com
ABVC | News | $0.9963 -2.32% -2.38% 460K

| -17.07% | O: -0.81% H: 0.0% C: 0.0%
first business year update biopharma

Kaival Brands Provides Business Update in Letter to Shareholders
Published: 2024-02-14 (Crawled : 21:00) - globenewswire.com
KAVL | $3.51 3.24% 3.13% 340K

| 27.34% | O: 0.37% H: 2.56% C: -2.61%
business brands update

ABVC Corporate Update and CEO's Letter to Shareholders
Published: 2023-08-07 (Crawled : 12:20) - globenewswire.com
ABVC | News | $0.9963 -2.32% -2.38% 460K

| -62.77% | O: -1.46% H: 1.85% C: -4.07%
update

ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)
Published: 2023-04-10 (Crawled : 13:20) - biospace.com/
ABVC | News | $0.9963 -2.32% -2.38% 460K

| 57.43% | O: -1.22% H: 4.28% C: 4.28%
abv-1601 update biopharma medical

ABVC BioPharma Provides Vitargus Update on Phase II Site Initiation Visit Conducted at Ramathibodi Hospital in Thailand
Published: 2023-04-06 (Crawled : 13:20) - biospace.com/
ABVC | News | $0.9963 -2.32% -2.38% 460K

| 63.46% | O: 0.0% H: 4.13% C: 3.83%
vitargus update biopharma

ABVC BioPharma Provides Vitargus® Update on Phase II Site Initiation Visit Conducted at Srinagarind Hospital in Thailand
Published: 2023-03-20 (Crawled : 12:20) - biospace.com/
ABVC | News | $0.9963 -2.32% -2.38% 460K

| 70.0% | O: 7.02% H: 7.46% C: 1.21%
vitargus update biopharma

ABVC BioPharma Provides 2023 Pipeline Update
Published: 2023-02-28 (Crawled : 14:00) - globenewswire.com
ABVC | News | $0.9963 -2.32% -2.38% 460K

| 47.83% | O: 0.0% H: 1.45% C: -3.77%
biopharma update pipeline

ABVC BioPharma Provides Vitargus® Update - Phase II Vitargus® Study Protocol Received Thai FDA Approval
Published: 2022-11-17 (Crawled : 14:00) - biospace.com/
ABVC | News | $0.9963 -2.32% -2.38% 460K

| 30.77% | O: 1.28% H: 0.0% C: -2.53%
vitargus fda biopharma approval update study

ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Study Update and Announces UCSF Institutional Review Board Approval
Published: 2022-09-23 (Crawled : 13:00) - globenewswire.com
ABVC | News | $0.9963 -2.32% -2.38% 460K

| 25.86% | O: 2.42% H: 25.3% C: 10.06%
biopharma adhd approval review update study

DSGT Reports 117% Revenue Growth in Q2 2022 - Update
Published: 2022-08-18 (Crawled : 14:20) - globenewswire.com
DSGT | $0.0001 52900.0% 21K

| -99.86% | O: 5.71% H: 0.0% C: -25.74%
update growth

ABVC BioPharma Provides Vitargus® Update
Published: 2022-08-18 (Crawled : 13:00) - globenewswire.com
ABVC | News | $0.9963 -2.32% -2.38% 460K

| 35.57% | O: 4.08% H: 18.76% C: 14.93%
vitargus biopharma update

ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update
Published: 2022-07-13 (Crawled : 13:20) - biospace.com/
ABVC | News | $0.9963 -2.32% -2.38% 460K